title: Academia-pharma partnerships for novel drug discovery: essential or nice to have?
authors.affiliation: a ImmunoGen Inc. , Waltham , MA , USA.
authors.forename: Michelle
authors.initials: M
authors.lastname: Palmer
authors.affiliation: b iDDPartners , Princeton Junction , NJ , USA.
authors.forename: Rathnam
authors.initials: R
authors.lastname: Chaguturu
mesh_terms: D000047:Academies and Institutes / Q000191:economics / Q000458:organization & administration; D015195:Drug Design; D055808:Drug Discovery / Q000191:economics / Q000379:methods*; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D006801:Humans; D055818:Public-Private Sector Partnerships / Q000191:economics / Q000458:organization & administration*
keywords: Academia–pharma partnerships; collaborative models; data reproducibility and waze; drug discovery; intellectual property; open innovation; technology transfer